ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

We aren’t showing our typical comparisons because the provider updated his/her primary specialty after we conducted our analysis. The updated address appears on this page.

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,786Medicare Part D Prescriptions Filled, Including Refills
$350K Total Retail Price of All Prescriptions
221 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
LEVOTHYROXINE SODIUM 389 382
LISINOPRIL 387 386
METOPROLOL TARTRATE 320 315
NAMENDA 320 319
DONEPEZIL HCL 294 294
SIMVASTATIN 270 266
FUROSEMIDE 222 215
AMLODIPINE BESYLATE 185 179
TRAMADOL HCL 168 149
MIRTAZAPINE 163 163
CITALOPRAM HBR 158 154
ATORVASTATIN CALCIUM 132 131
POTASSIUM CHLORIDE 118 115
WARFARIN SODIUM 118 116
OMEPRAZOLE 108 108
FAMOTIDINE 106 106
DIGOXIN 98 98
ESCITALOPRAM OXALATE 84 84
LEVETIRACETAM 83 82
RANITIDINE HCL 83 79
CLOPIDOGREL 81 81
ISOSORBIDE MONONITRATE ER 80 79
SPIRONOLACTONE 80 80
GABAPENTIN 79 77
LANTUS 72 72
SERTRALINE HCL 71 63
HYDROCODONE-ACETAMINOPHEN 70 69 S3
ALBUTEROL SULFATE 70 70
FORTICAL 69 69
METOPROLOL SUCCINATE 65 64
PRAVASTATIN SODIUM 65 63
PANTOPRAZOLE SODIUM 64 61
CARVEDILOL 63 62
CILOSTAZOL 56 56
POLYETHYLENE GLYCOL 3350 54 54
FENTANYL 51 51 S2
PAROXETINE HCL 50 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.